Skip to Content


In the US, Capreomycin (capreomycin systemic) is a member of the drug class streptomyces derivatives and is used to treat Tuberculosis, Active.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antibacterial: Polypeptide

Chemical Name

Antibiotic produced by Streptomyces capreolus

Foreign Names

  • Capreomycinum (Latin)
  • Capreomycin (German)
  • Capréomycine (French)
  • Capreomicina (Spanish)

Generic Names

Brand Names

  • Helpomycin
    Unifarm, Romania
  • Kapocin
    Macleods, Georgia
  • Capastat
    Akorn, United States; Aspen, Australia; Dista, Spain; IFET, Greece; King Pharmaceuticals, United Kingdom; Lilly, Greece; Lilly, Russian Federation
  • Capreomycin
    Bristol-Myers Squibb, United Kingdom
  • Capreomycin-Hisun Pharm
    Hisun, China
  • Lykocin
    Lyka Labs Ltd, Russian Federation

International Drug Name Search


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.